Myocardial Infarction Optimising Drug Therapy
|
Ace-inhibitors after Myocardial Infarction.
The evidence in favour of ace-inhibitor therapy after myocardial infarction is compelling.
- Patients with significant left ventricular impairment or with heart failure get large benefits from these agents- these agents reduce mortality, reduce admissions to hospital with heart failure, and reduce adverse left ventricular remodelling after infarction.
- There is evidence that maximal ace-inhibitor therapy provides additional benefits to moderate dosage ace-inhibitor therapy.
- However, there will be some patients in whom we wish to start beta-blocker therapy but whose systolic blood pressue is just on 90mmHg. If these patients are on the maximal dose of ace-inhibitor, I think it is reasonable to reduce the dose of ace-inhibitor therapy to enable use of beta-blockers.
- There is evidence that all patients with atherosclerotic disease should be on ace-inhibitor therapy, including those with good LV systolic function.
Hitesh Patel, Cardiologist
5th June, 2004
Users should read this document on "copyright" and "conditions of use".
|
  |